CD44 and rheumatoid arthritis: Blocking the binding of HA to CD44 significantly reduced the severity of inflammatory diseases, such as rheumatoid arthritis (22), autoimmune diabetes (23), and allergic encephalomyelitis (24), but there is still lack of evidence that supports their role in CP/CPPS.